ABOUT US OUR PRODUCTS & PIPELINE BUSINESS DEVELOPMENT OUR INVESTORS PRESS ROOM CONTACT US
 
KEY PERSONNEL

BOARD OF DIRECTORS

DEVELOPMENT ADVISORY BOARD
 

Prof John Bell

Prof Graham Boulnois

Dr Richard Auty

Dr George Carter

Dr Paul O’Byrne

Dr Pete Strong

Dr Kazumi Shiosaki

  Dr Richard Auty
 

Dr Richard Auty is Director of Salient Consulting Ltd. Previously, he was the Non-Executive Chairman of MNL Pharmaceuticals Ltd, a private UK drug discovery and development company focused on the exploitation of imino sugar therapeutics for the prevention and treatment of disease. He was also a Non-Executive Director of KuDOS Pharmaceuticals Ltd, which is involved in the discovery and development of drugs based upon the science of DNA damage sensing, signalling and repair to address unmet medical needs in cancer treatment.

Dr Auty is a member of the Expert Scientific Advisory Committee of the Medicines for Malaria Venture and Visiting Professor of Medicine at the University of Malawi. He is also R&D Director of Zeneca Pharmaceuticals and Non-Executive Director of Cantab plc. He is a past member of the Medicines Commission and also the Council of the MRC.

Oxagen Limited, 91 Milton Park, Abingdon, Oxfordshire OX14 4RY   t : +44(0) 1235 443300  f: +44(0) 1235 443301  e: oxagen@oxagen.co.uk